FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570992506> ?p ?o ?g. }

• W1570992506 endingPage "392" @default.
• W1570992506 startingPage "383" @default.
• W1570992506 abstract "WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Active metabolism of clopidogrel is mainly mediated by CYP2C19. There are genetic differences in the activity of CYP2C19. Therefore, active metabolism of clopidogrel is affected by CYP2C19 genotypes. • The main metabolizing enzyme of proton pump inhibitors (PPIs) is CYP2C19. Therefore, the anti‐platelet function of clopidogrel is attenuated by concomitant use of PPIs. • There are differences in the metabolic disposition among different PPIs. Affinity to CYP2C19 differs among different PPIs. WHAT THIS STUDY ADDS • Whether a PPI attenuates the efficacy of clopidogrel depends on CYP2C19. Individuals who are decreased metabolizers, i.e. carriers the allele of CYP2C19 *2 and/or *3, are more likely to convert from ‘responder’ to ‘non‐responder’ to clopidogrel when placed on a concomitant PPI. • We found that rabeprazole, whose affinity to CYP2C19 has been considered lower, attenuated the efficacy of clopidogrel. • We tested whether the separate dosing of a PPI and clopidogrel decreased the risk of attenuation of clopidogrel efficacy. We unfortunately found that separate dosing did not avoid the problematic interaction between clopidogrel and a PPI in subject's with CYP2C19 *2 and/or CYP2C19 *3. AIMS The efficacy of clopidogrel is influenced by CYP2C19 genotypes and substrates of CYP2C19, such as proton pump inhibitors (PPIs). We assessed the influence of three different PPIs on the anti‐platelet function of clopidogrel in relation to CYP2C19 genotype status. METHODS Thirty‐nine healthy volunteers with different CYP2C19 genotypes took clopidogrel 75 mg with or without omeprazole 20 mg, lansoprazole 30 mg or rabeprazole 20 mg in the morning for 7 days. The influence of the three PPIs on the anti‐platelet function of clopidogrel was determined. A less than 30% inhibition of platelet aggregation (IPA) during clopidogrel dosing was defined as a ‘low responder’. We also examined whether evening dosing of omeprazole could prevent the interaction with clopidogrel dosed in the morning. RESULTS In rapid metabolizers (RMs, *1/*1, n = 15) of CYP2C19, omeprazole and rabeprazole significantly attenuated the anti‐platelet function of clopidogrel. In decreased metabolizers (DMs, carriers of *2 and/or *3, n = 24), there was a large variation in IPA and there was a trend but no significant decrease in IPA when placed on a concomitant PPI. Some DMs became ‘low‐responders’ when placed on a concomitant PPI. Evening omeprazole dose in RMs did not seem to cause a significant decrease in IPA in contrast to morning dosing, but did so in DMs. CONCLUSIONS The three PPIs affected the efficacy of clopidogrel to different degrees. Both omeprazole and rabeprazole significantly decreased IPA in RMs but not DMs, although there was a trend towards lower IPA in DMs. Morning and evening dosing of omeprazole were both associated with lower IPA in DMs." @default.
• W1570992506 created "2016-06-24" @default.
• W1570992506 creator A5016748939 @default.
• W1570992506 creator A5033302261 @default.
• W1570992506 creator A5088804804 @default.
• W1570992506 date "2010-08-16" @default.
• W1570992506 modified "2023-09-30" @default.
• W1570992506 title "Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes" @default.
• W1570992506 cites W1004452157 @default.
• W1570992506 cites W1845429887 @default.
• W1570992506 cites W1976577625 @default.
• W1570992506 cites W1977112096 @default.
• W1570992506 cites W1981132890 @default.
• W1570992506 cites W1985059672 @default.
• W1570992506 cites W1986627308 @default.
• W1570992506 cites W1988838886 @default.
• W1570992506 cites W2002929828 @default.
• W1570992506 cites W2014857074 @default.
• W1570992506 cites W2016950747 @default.
• W1570992506 cites W2044901769 @default.
• W1570992506 cites W2045657987 @default.
• W1570992506 cites W2046551905 @default.
• W1570992506 cites W2048834836 @default.
• W1570992506 cites W2062195164 @default.
• W1570992506 cites W2071335057 @default.
• W1570992506 cites W2076472818 @default.
• W1570992506 cites W2081558811 @default.
• W1570992506 cites W2093265279 @default.
• W1570992506 cites W2097803937 @default.
• W1570992506 cites W2102393690 @default.
• W1570992506 cites W2103481781 @default.
• W1570992506 cites W2105005467 @default.
• W1570992506 cites W2119499480 @default.
• W1570992506 cites W2120642548 @default.
• W1570992506 cites W2128228188 @default.
• W1570992506 cites W2129001881 @default.
• W1570992506 cites W2141951952 @default.
• W1570992506 cites W2143742417 @default.
• W1570992506 cites W2143777566 @default.
• W1570992506 cites W2145218953 @default.
• W1570992506 cites W2150912899 @default.
• W1570992506 cites W2159858918 @default.
• W1570992506 cites W2161254333 @default.
• W1570992506 cites W2163961571 @default.
• W1570992506 cites W2170125927 @default.
• W1570992506 cites W4211207317 @default.
• W1570992506 cites W4249056819 @default.
• W1570992506 doi "https://doi.org/10.1111/j.1365-2125.2010.03717.x" @default.
• W1570992506 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2949911" @default.
• W1570992506 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20716239" @default.
• W1570992506 hasPublicationYear "2010" @default.
• W1570992506 type Work @default.
• W1570992506 sameAs 1570992506 @default.
• W1570992506 citedByCount "83" @default.
• W1570992506 countsByYear W15709925062012 @default.
• W1570992506 countsByYear W15709925062013 @default.
• W1570992506 countsByYear W15709925062014 @default.
• W1570992506 countsByYear W15709925062015 @default.
• W1570992506 countsByYear W15709925062016 @default.
• W1570992506 countsByYear W15709925062017 @default.
• W1570992506 countsByYear W15709925062018 @default.
• W1570992506 countsByYear W15709925062019 @default.
• W1570992506 countsByYear W15709925062020 @default.
• W1570992506 countsByYear W15709925062021 @default.
• W1570992506 countsByYear W15709925062022 @default.
• W1570992506 countsByYear W15709925062023 @default.
• W1570992506 crossrefType "journal-article" @default.
• W1570992506 hasAuthorship W1570992506A5016748939 @default.
• W1570992506 hasAuthorship W1570992506A5033302261 @default.
• W1570992506 hasAuthorship W1570992506A5088804804 @default.
• W1570992506 hasBestOaLocation W15709925062 @default.
• W1570992506 hasConcept C126322002 @default.
• W1570992506 hasConcept C140840227 @default.
• W1570992506 hasConcept C2777498785 @default.
• W1570992506 hasConcept C2777628954 @default.
• W1570992506 hasConcept C2777849778 @default.
• W1570992506 hasConcept C2778204628 @default.
• W1570992506 hasConcept C2778715759 @default.
• W1570992506 hasConcept C2779116819 @default.
• W1570992506 hasConcept C2781025758 @default.
• W1570992506 hasConcept C526171541 @default.
• W1570992506 hasConcept C62231903 @default.
• W1570992506 hasConcept C71924100 @default.
• W1570992506 hasConcept C89560881 @default.
• W1570992506 hasConcept C98274493 @default.
• W1570992506 hasConceptScore W1570992506C126322002 @default.
• W1570992506 hasConceptScore W1570992506C140840227 @default.
• W1570992506 hasConceptScore W1570992506C2777498785 @default.
• W1570992506 hasConceptScore W1570992506C2777628954 @default.
• W1570992506 hasConceptScore W1570992506C2777849778 @default.
• W1570992506 hasConceptScore W1570992506C2778204628 @default.
• W1570992506 hasConceptScore W1570992506C2778715759 @default.
• W1570992506 hasConceptScore W1570992506C2779116819 @default.
• W1570992506 hasConceptScore W1570992506C2781025758 @default.
• W1570992506 hasConceptScore W1570992506C526171541 @default.
• W1570992506 hasConceptScore W1570992506C62231903 @default.
• W1570992506 hasConceptScore W1570992506C71924100 @default.
• W1570992506 hasConceptScore W1570992506C89560881 @default.

• next